Related Experiment Videos
Antioxidant stobadine and neurobehavioural development of the rat offspring
M Dubovický1, E Ujházy, P Kovacovský
1Institute of Experimental Pharmacology, Slovak Academy of Sciences, Bratislava. exfadubm@savba.savba.sk
Insights
Stobadine (STO) shows no adverse effects on pregnant or lactating dams or their offspring. This neuroprotective drug supports healthy neurobehavioral development in newborns.
Area of Science:
- Pharmacology
- Neuroscience
- Developmental Biology
Background:
- Stobadine (STO) is recognized for its neuroprotective and cardioprotective potential, attributed to its significant antioxidative properties.
- Investigating the safety of potential therapeutic agents during sensitive developmental periods, such as pregnancy and lactation, is crucial.
Purpose of the Study:
- To evaluate the safety and impact of oral Stobadine (STO) administration on the neurobehavioral development of offspring.
- To assess potential adverse effects of STO on dams during pregnancy and lactation.
Main Methods:
- Oral administration of Stobadine (STO) at varying doses (5, 15, and 50 mg/kg/d) to pregnant and lactating dams.
- Comprehensive assessment of offspring neurobehavioral development, including growth, maturation, sensory and neuromotor functions, activity levels, emotional reactivity, and learning processes.
Main Results:
- Long-term Stobadine (STO) administration did not negatively impact the course of pregnancy or lactation in the dams.
- No adverse effects were observed in the neurobehavioral development of the offspring exposed to Stobadine (STO) in utero and during lactation.
Conclusions:
- Oral Stobadine (STO) administration is safe during pregnancy and lactation.
- Stobadine (STO) does not adversely affect the neurobehavioral development of offspring, supporting its potential as a neuroprotective agent.
Abstract:
Stobadine (STO) is a potential neuro- and cardioprotective drug with high antioxidative properties. The presented study investigated the effects of oral STO administration (5, 15 and 50 mg/kg/d) during pregnancy and lactation to dams on neurobehavioural development of their offspring (body growth and maturation, sensory functions, neuromotor and reflex development, levels of activity and emotional reactivity, memory and learning processes). The results of our experiments showed that long-term administration of STO had no adverse effects on the course of pregnancy and lactation in dams and on the neurobehavioural development of offspring.